|
2,7,12-三氨基-5H-二茚基[1,2-a:1',2'-c]芴-5,10,15-三酮
|
T302763-250mg
|
≥98% |
209112-55-0 |
250mg
|
¥ 962.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1-甲苯磺酰基-1H-吲哚
|
T290852-5g
|
≥98% |
1073354-51-4 |
5g
|
¥ 2199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1-甲苯磺酰基-1H-吲哚
|
T290852-250mg
|
≥98% |
1073354-51-4 |
250mg
|
¥ 299.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
呋喃-2-硼酸频哪醇酯
|
T290788-5g
|
≥97% |
374790-93-9 |
5g
|
¥ 169.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
呋喃-2-硼酸频哪醇酯
|
T290788-25g
|
≥97% |
374790-93-9 |
25g
|
¥ 592.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
呋喃-2-硼酸频哪醇酯
|
T290788-100g
|
≥97% |
374790-93-9 |
100g
|
¥ 1896.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TCS 21311,JAK3抑制剂
|
T287291-5mg
|
Moligand™, ≥98% |
1260181-14-3 |
5mg
|
¥ 629.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TCS 21311,JAK3抑制剂
|
T287291-25mg
|
Moligand™, ≥98% |
1260181-14-3 |
25mg
|
¥ 1995.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TCS 21311,JAK3抑制剂
|
T287291-1mg
|
Moligand™, ≥98% |
1260181-14-3 |
1mg
|
¥ 179.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TCS 21311,JAK3抑制剂
|
T287291-100mg
|
Moligand™, ≥98% |
1260181-14-3 |
100mg
|
¥ 5764.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
替尼达普
|
T286898-5mg
|
Moligand™, ≥98% |
120210-48-2 |
5mg
|
¥ 499.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
替尼达普
|
T286898-100mg
|
Moligand™, ≥98% |
120210-48-2 |
100mg
|
¥ 4969.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2,6,6-四甲基-3,5-庚二酮基银(I)
|
T282951-50mg
|
≥99.9% metals basis |
79827-25-1 |
50mg
|
¥ 189.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2,6,6-四甲基-3,5-庚二酮基银(I)
|
T282951-250mg
|
≥99.9% metals basis |
79827-25-1 |
250mg
|
¥ 649.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-乙氧基-4-叔丁基苯甲酸
|
T195095-25g
|
≥97% |
796875-53-1 |
25g
|
¥ 1518.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6,7-四氢-3H-咪唑并[4,5-C]吡啶二盐酸盐
|
T194233-25g
|
≥97% |
62002-31-7 |
25g
|
¥ 1077.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-溴异吲哚啉-2-碳酸叔丁酯
|
T191923-5g
|
≥98% |
201940-08-1 |
5g
|
¥ 299.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-氧代-2,7-二氮杂螺[4.5]癸烷-7-羧酸叔丁酯
|
T178244-5g
|
≥97% |
923009-50-1 |
5g
|
¥ 1923.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-氧代-2,7-二氮杂螺[4.5]癸烷-7-羧酸叔丁酯
|
T178244-50mg
|
≥97% |
923009-50-1 |
50mg
|
¥ 59.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-氧代-2,7-二氮杂螺[4.5]癸烷-7-羧酸叔丁酯
|
T178244-250mg
|
≥97% |
923009-50-1 |
250mg
|
¥ 171.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[2-(甲基氨基)乙基]哌啶-1-甲酸叔丁酯
|
T178071-50mg
|
≥97% |
896103-62-1 |
50mg
|
¥ 259.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[2-(甲基氨基)乙基]哌啶-1-甲酸叔丁酯
|
T178071-250mg
|
≥97% |
896103-62-1 |
250mg
|
¥ 892.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
草酸乙基叔丁酯
|
T176640-5g
|
≥97% |
50624-94-7 |
5g
|
¥ 689.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
草酸乙基叔丁酯
|
T176640-25g
|
≥97% |
50624-94-7 |
25g
|
¥ 2459.9
|
期货,请咨询 |
|
0 |
阿拉丁 |